Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (SinaAmpholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis

• Päätekijät: Seyed Ebrahim Eskandari (Tekijä), Alireza Firooz (Tekijä), Mansour Nassiri-Kashani (Tekijä), Mahmoud Reza Jaafari (Tekijä), Amir Javadi (Tekijä), Akram Miramin-Mohammadi (Tekijä), Hossein Valian-Keshavarz (Tekijä), Ali Khamesipour (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Tehran University of Medical Sciences, 2018-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Development of a topical treatment for cutaneous leishmaniasis (CL) is an important step in the im­provement of lesion management. Amphotericin B (AmB) is effective against Leishmania species but it is toxic, a Nano-liposomal form of AmB with a size of about 100nm (Lip-AmB) was developed...